Search
Search Results
##search.searchResults.foundPlural##
-
-
TYROSINE KINASE INHIBITORS AND INTERFERON
2930PDF: 1463HTML: 3089Cover Letter: 224 -
-
ClinicaI Reversible Myelopathy in T-Cell Lymphoblastic Lymphoma Treated with Nelarabine and Radiotherapy: Report of a Case and Review of Literature of an Increasing Complication
2442PDF: 1021HTML: 1656Fig 1: 204Tab I: 228Cover Letter: 223 -
SOCIOECONOMIC STATUS IS GLOBALLY A PROGNOSTIC FACTOR FOR OVERALL SURVIVAL OF MULTIPLE MYELOMA PATIENTS; SYNTHESIS OF STUDIES AND REVIEW OF THE LITERATURE SES as prognostic factor for myeloma survival
2113PDF: 873HTML: 354 -
THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA
2535PDF: 810HTML: 1743 -
BLINATUMOMAB IN THE THERAPY OF ACUTE B-LYMPHOID LEUKEMIA BLINATUMOMAB and ALL
1709PDF: 1130HTML: 147 -
CANDIDA ASSOCIATED BLOODSTREAM INFECTIONS IN PEDIATRIC HEMATOLOGY PATIENTS: SINGLE CENTER EXPERIENCE
4462PDF: 940HTML: 1357Table1: 194 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1464PDF: 844HTML: 3129 -
Acquired Hemophilia A successfully treated with rituximab
2157PDF: 1173HTML: 1479Figure 1: 205 -
OUTCOME OF ANTIFUNGAL COMBINATION THERAPY FOR INVASIVE MOLD INFECTIONS IN HEMATOLOGICAL PATIENTS IS INDEPENDENT OF THE CHOSEN COMBINATION
1174PDF: 560HTML: 1703Figures: 183Fifures Sanz: 190tables Sanz: 192Untitled: 188 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1446HTML: 629PDF: 864 -
THERAPY-RELATED MYELOID NEOPLASMS: CONSIDERATIONS FOR PATIENTS’ CLINICAL EVALUATION. Clinical Evaluation of T-AML
1927PDF: 852HTML: 251 -
WHAT ARE FUNGAL INFECTIONS?
4300PDF: 2451HTML: 27657de Pauw: 257 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4534PDF: 1759HTML: 1170 -
OCCURRENCE OF SECONDARY MALIGNANCIES IN CHRONIC MYELOID LEUKEMIA DURING THERAPY WITH IMATINIB MESYLATE-SINGLE INSTITUTION EXPERIENCE
2317PDF: 1083HTML: 2023Characteristic of study group: 214 -
GASTROINTESTINAL MYELOID SARCOMA A CASE PRESENTATION AND CRITICAL REVIEW OF THE LITERATURE GASTROINTESTINAL MYELOID SARCOMA
1563PDF: 651HTML: 344 -
CENTRAL NERVOUS SYSTEM INVOLVEMENT IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: DIAGNOSTIC TOOLS, PROPHYLAXIS AND THERAPY
4255PDF: 1976HTML: 5498Table 1: 224 -
ARA-C, IDARUBICINE AND GENTUZUMAB OZOGAMICIN (AIM) AS SALVAGE TREATMENT IN ADVANCED ACUTE MYELOID LEUKEMIA PATIENTS
1727PDF: 841HTML: 962cover letter: 289 -
EFFICACY OF VENETOCLAX COMBINED WITH AZACITIDINE IN ELDERLY PATIENTS WITH RELAPSED ACUTE MYELOID LEUKEMIA
1539PDF: 814Suppl. Files: 342Html: 143 -
IMPACT OF COVID-19 ON OUTCOMES OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES: A MULTI-CENTER, RETROSPECTIVE STUDY COVID-19 and hematologic malignancy
1733PDF: 824HTML: 223 -
NON-SECRETORY MYELOMA: READY FOR A NEW DEFINITION?
3334PDF: 1736HTML: 1149 -
ADVANCED HODGKIN LYMPHOMA: A NEW ERA OF THERAPY
2176PDF: 1343HTML: 3509 -
Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and granulocyte-colony stimulating factor with subsequent bridging to myeloablative allogeneic hematopoietic stem cell transplantation Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and G-CSF
1831PDF: 598HTML: 340 -
NEW THERAPEUTIC OPTIONS FOR THE TREATMENT OF SICKLE CELL DISEASE Guest Editor: Raffaella Origa
7033PDF: 3717HTML: 811







